• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲胎蛋白水平极高对接受肝切除术的极早期肝细胞癌有何影响?

Does very high alpha-fetoprotein affect very early hepatocellular carcinoma receiving hepatectomy?

作者信息

Chou Hong-Shiue, Lee Chen-Fang, Hung Hao-Chien, Lai Yin, Lee Jin-Chiao, Wang Yu-Chao, Cheng Chih-Hsien, Wu Tsung-Han, Wu Ting-Jung, Chan Kun-Ming, Lee Wei-Chen

机构信息

Division of Liver and Transplantation Surgery, Chang-Gung Memorial Hospital, Taoyuan, Taiwan.

Chang-Gung University College of Medicine, Taoyuan, Taiwan.

出版信息

Langenbecks Arch Surg. 2025 Apr 9;410(1):124. doi: 10.1007/s00423-025-03675-y.

DOI:10.1007/s00423-025-03675-y
PMID:40205183
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11982121/
Abstract

BACKGROUND

Following liver resection (LR), recurrence is critical to the prognosis of hepatocellular carcinoma (HCC). A higher level of alpha-fetoprotein (AFP) is typically associated with poor prognosis and recurrence concerns. Specifically, we attempted to determine whether high AFP (> 1,000ng/ml) and other potentially relevant factors affect survivals of patients with BCLC stage 0 HCC after LR.

METHODS

This retrospective study focused on 223 patients who received LR for stage 0 HCC of BCLC between 2004 and 2012. In patients with a low AFP (n = 200) and a high AFP (n = 23), we conducted chi-squares, independent t-test, Cox regression, and Kaplan-Meier survival analyses to investigate the relationship between clinicopathologic variables and outcomes.

RESULTS

The long-term disease-free survival (DFS) (p = 0.799) and the overall survival (OS) (p = 0.942) between the low and high AFP groups were comparable. The two groups' clinicopathologic features-tumor size, presence of a tumor capsule, cirrhosis, histology activity index (HAI), and microvascular invasion-appear to be similar. Additionally, we observed significant associations between HCC recurrence and ICG R15, HAI score, and cirrhosis, but not AFP.

CONCLUSIONS

In stage 0 HCC, the consideration of curative-intent therapy in these patients should begin as soon as possible, irrespective of AFP levels.

摘要

背景

肝切除术后,复发是影响肝细胞癌(HCC)预后的关键因素。甲胎蛋白(AFP)水平升高通常与预后不良及复发风险相关。具体而言,我们试图确定高AFP水平(>1000ng/ml)及其他潜在相关因素是否会影响BCLC 0期HCC患者肝切除术后的生存情况。

方法

这项回顾性研究聚焦于2004年至2012年间接受BCLC 0期HCC肝切除术的223例患者。对于低AFP水平患者(n = 200)和高AFP水平患者(n = 23),我们进行了卡方检验、独立t检验、Cox回归分析和Kaplan-Meier生存分析,以研究临床病理变量与预后之间的关系。

结果

低AFP组和高AFP组之间的长期无病生存率(DFS)(p = 0.799)和总生存率(OS)(p = 0.942)相当。两组的临床病理特征,如肿瘤大小、肿瘤包膜、肝硬化、组织学活动指数(HAI)和微血管侵犯,似乎相似。此外,我们观察到HCC复发与吲哚菁绿滞留率15分钟(ICG R15)、HAI评分和肝硬化之间存在显著关联,但与AFP无关。

结论

在0期HCC中,无论AFP水平如何,应尽早考虑对这些患者进行根治性治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/922b/11982121/1815e27dfe59/423_2025_3675_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/922b/11982121/29be225c57c8/423_2025_3675_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/922b/11982121/65e4111786c0/423_2025_3675_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/922b/11982121/bb03f23de269/423_2025_3675_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/922b/11982121/1815e27dfe59/423_2025_3675_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/922b/11982121/29be225c57c8/423_2025_3675_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/922b/11982121/65e4111786c0/423_2025_3675_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/922b/11982121/bb03f23de269/423_2025_3675_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/922b/11982121/1815e27dfe59/423_2025_3675_Fig4_HTML.jpg

相似文献

1
Does very high alpha-fetoprotein affect very early hepatocellular carcinoma receiving hepatectomy?甲胎蛋白水平极高对接受肝切除术的极早期肝细胞癌有何影响?
Langenbecks Arch Surg. 2025 Apr 9;410(1):124. doi: 10.1007/s00423-025-03675-y.
2
Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.巴塞罗那临床肝癌分期 B 期肝癌行肝切除术的生存结局。
World J Surg Oncol. 2017 Aug 22;15(1):156. doi: 10.1186/s12957-017-1229-x.
3
Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.术前甲胎蛋白和脱γ-羧基凝血酶原在肝细胞癌患者中的预后作用
World J Gastroenterol. 2015 Apr 28;21(16):4933-45. doi: 10.3748/wjg.v21.i16.4933.
4
[A new prognostic score system of hepatocellular carcinoma following hepatectomy].[一种肝切除术后肝细胞癌的新预后评分系统]
Zhonghua Zhong Liu Za Zhi. 2017 Dec 23;39(12):903-909. doi: 10.3760/cma.j.issn.0253-3766.2017.12.005.
5
Clinical Significance of Alpha-Fetoprotein in Alpha-Fetoprotein Negative Hepatocellular Carcinoma Underwent Curative Resection.甲胎蛋白阴性肝癌根治性切除术后甲胎蛋白的临床意义。
Dig Dis Sci. 2021 Dec;66(12):4545-4556. doi: 10.1007/s10620-020-06797-z. Epub 2021 Mar 16.
6
The Prognostic Value of Alpha-Fetoprotein Ratio in Patients With Resectable Alpha-Fetoprotein-Negative Hepatocellular Carcinoma.可切除甲胎蛋白阴性肝细胞癌患者甲胎蛋白比值的预后价值。
Am Surg. 2024 Jun;90(6):1240-1249. doi: 10.1177/00031348241227202. Epub 2024 Jan 12.
7
Prognostic Significance of Preoperative Serum Alpha- fetoprotein in Hepatocellular Carcinoma and Correlation with Clinicopathological Factors: a Single-center Experience from China.术前血清甲胎蛋白在肝细胞癌中的预后意义及其与临床病理因素的相关性:来自中国的单中心经验
Asian Pac J Cancer Prev. 2015;16(10):4421-7. doi: 10.7314/apjcp.2015.16.10.4421.
8
Correlation analysis of preoperative serum alpha-fetoprotein (AFP) level and prognosis of hepatocellular carcinoma (HCC) after hepatectomy.术前血清甲胎蛋白(AFP)水平与肝癌(HCC)肝切除术后预后的相关性分析。
World J Surg Oncol. 2013 Aug 27;11:212. doi: 10.1186/1477-7819-11-212.
9
Cluster analysis of hepatocellular carcinoma prognosis using preoperative alpha-fetoprotein and des-gamma-carboxy prothrombin levels: a multi-institutional study.利用术前甲胎蛋白和异常凝血酶原水平对肝细胞癌预后进行聚类分析:一项多机构研究
J Gastrointest Surg. 2025 Apr;29(4):101980. doi: 10.1016/j.gassur.2025.101980. Epub 2025 Jan 28.
10
High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy.术前血清骨膜蛋白水平高与肝癌患者肝切除术后预后不良相关。
Eur J Surg Oncol. 2013 Oct;39(10):1129-35. doi: 10.1016/j.ejso.2013.06.023. Epub 2013 Jul 31.

本文引用的文献

1
Comparison of laparoscopic hepatectomy and percutaneous radiofrequency ablation for the treatment of small hepatocellular carcinoma: a meta-analysis.腹腔镜肝切除术与经皮射频消融治疗小肝细胞癌的比较:一项荟萃分析。
BMC Surg. 2024 Mar 5;24(1):83. doi: 10.1186/s12893-024-02376-5.
2
Role of microvascular invasion in early recurrence of hepatocellular carcinoma after liver resection: A literature review.微血管侵犯在肝切除术后肝细胞癌早期复发中的作用:文献综述。
Asian J Surg. 2024 May;47(5):2138-2143. doi: 10.1016/j.asjsur.2024.02.115. Epub 2024 Mar 5.
3
Electrochemical immuno-biosensors for the detection of the tumor marker alpha-fetoprotein: A review.
电化学免疫生物传感器用于检测肿瘤标志物甲胎蛋白:综述。
Talanta. 2024 May 1;271:125638. doi: 10.1016/j.talanta.2024.125638. Epub 2024 Jan 18.
4
EpCAM-positive circulating tumor cells and serum AFP levels predict outcome after curative resection of hepatocellular carcinoma.EpCAM 阳性循环肿瘤细胞和血清 AFP 水平可预测肝癌根治性切除术后的预后。
Sci Rep. 2023 Nov 27;13(1):20827. doi: 10.1038/s41598-023-47580-0.
5
AFP deletion leads to anti-tumorigenic but pro-metastatic roles in liver cancers with concomitant CTNNB1 mutations.AFP 缺失导致同时伴有 CTNNB1 突变的肝癌具有抗肿瘤但促转移的作用。
Cancer Lett. 2023 Jul 10;566:216240. doi: 10.1016/j.canlet.2023.216240. Epub 2023 May 20.
6
Improving Management of Portal Hypertension: The Potential Benefit of Non-Etiological Therapies in Cirrhosis.改善门静脉高压的管理:非病因治疗在肝硬化中的潜在益处。
J Clin Med. 2023 Jan 25;12(3):934. doi: 10.3390/jcm12030934.
7
Is liver regeneration key in hepatocellular carcinoma development?肝再生是肝细胞癌发展的关键因素吗?
Trends Cancer. 2023 Feb;9(2):140-157. doi: 10.1016/j.trecan.2022.10.005. Epub 2022 Nov 5.
8
Association of alpha-fetoprotein and metastasis for small hepatocellular carcinoma: A propensity-matched analysis.甲胎蛋白与小肝细胞癌转移的相关性:倾向匹配分析。
Sci Rep. 2022 Sep 20;12(1):15676. doi: 10.1038/s41598-022-19531-8.
9
Splenic Volume, an Easy-To-Use Predictor of HCC Late Recurrence for HCC Patients After Hepatectomy.脾脏体积,一种用于预测肝癌患者肝切除术后肝癌晚期复发的简便指标。
Front Oncol. 2022 May 24;12:876668. doi: 10.3389/fonc.2022.876668. eCollection 2022.
10
Reappraisal of the roles of alpha-fetoprotein in hepatocellular carcinoma surveillance using large-scale nationwide database and hospital-based information.利用大规模全国性数据库和基于医院的信息重新评估甲胎蛋白在肝细胞癌监测中的作用。
J Formos Med Assoc. 2022 Oct;121(10):2085-2092. doi: 10.1016/j.jfma.2022.04.001. Epub 2022 Apr 19.